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Introduction
During the past decades, autopsy rates have been 
declining worldwide. Th  e non-forensic, clinical autopsy 
rate at large hospitals in the United States dropped from 
41% in 1964 to 22% in 1975 [1]. In spite of this decline, 
the post-mortem examination remains clinically relevant 
for time-honoured reasons: the information obtained 
helps to understand diseases; it provides essential 
feedback for the clinician and leads to quality assessment 
and educa  tion; and data from it are important for 
epidemiologists [2].
We analyzed reports that compare post-mortem cause 
of death with clinical diagnosis. Th  e discrepancies 
between these two were classiﬁ  ed into four categories 
according to Goldman’s criteria (Table 1) [3]. Th  is  article 
has the goal of convincing intensivists of the role of 
autopsy and gives an overview of the studies performed 
in the ICU.
Reasons for the decline in autopsy rate
Costs
Th   e costs for post-mortem analysis cannot be charged to 
family members since autopsy ﬁ  ndings are irrelevant for 
the management of their relative. Hospital administrators 
are not easily convinced to spend money on procedures 
lacking an immediate impact on patient management 
and just for teaching purposes [4,5]. In Belgium, the cost 
of an autopsy is estimated at 473 euros and is carried by 
the social security system. In London, the cost of one 
autopsy is 850 euros when the costs for building a 
mortuary are taken into account.
Judicial factors
In the US, some authors claim that the most important 
factor explaining the decrease in the autopsy rate is that a 
minimum number of autopsies is no longer needed for 
accreditation by the Joint Commission on Accreditation 
of Hospitals. Some clinicians also seem to be more 
reluctant to seek consent out of fear of litigation since 
autopsy can reveal missed diagnoses [4].
Communication with patients’ relatives
Because of the growing impact of the opinions of patients 
and their relatives, physicians are often forced to discuss 
necropsy with them. As a result, the autopsy rate in 
France has markedly declined after 1994 (from 15% to 
3%), the year that bioethics law impelled physicians to 
inform relatives about the performance of a post-mortem 
examination [6]. However, it is not clear what the attitude 
of relatives is. In a Swedish study, 84% reported accepting 
an autopsy for themselves and 80% for a next of kin [7]. 
In a study performed in a surgical ICU, relatives refused 2 
of 27 autopsy requests. Nevertheless, the autopsy rate 
was only 25% [8]. Th   is demonstrates that the low autopsy 
rate reﬂ  ects a low autopsy request rate on the part of 
clinicians more than refusal by relatives.
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recommended strongly by the treating physician. In one 
study based on physician and surrogate responses, the 
expected autopsy rate was 42%, while the actual autopsy 
rate was 23% [9]. Training physicians how to recommend 
autopsies may increase autopsy rates.
Reluctance of pathologists
Another reason for the decline in autopsy rates is the 
growing reluctance of pathologists to perform autopsies. 
Several studies analyzing the delay of pathology reports 
show a long delay (up to 90 days) [6]. Th   is indicates a lack 
of interest in autopsy ﬁ  ndings, both from pathologists 
and clinicians. Th  e reasons for this are many. First, 
pathologists are experiencing an increasing workload. 
Secondly, since infectious diseases are rising, pathologists 
fear the risk of infection [10]. Finally, autopsies now 
contribute little to the scientiﬁ  c output of the pathology 
department, with only 6% of the published articles being 
based on autopsy ﬁ  ndings [6].
Modern technology
It can be argued that the sensitivity of modern diagnostic 
methods would reduce diagnostic errors to an extent that 
autopsies would be unnecessary. However, this reasoning 
was not conﬁ  rmed by a study by Goldman and colleagues 
[3], who studied the time course of diagnostic errors 
during the 1960s, 1970s and 1980s and found no 
diﬀ   erences among the three periods: in all three eras 
about 10% of the autopsies revealed a class I missed 
diagnosis (Table 1).
Analyses of diagnostic error rates, adjusted for case 
mix, country and autopsy rate, yielded stable ﬁ  gures for 
major missed diagnoses throughout the past three 
decades [11]. A possible explanation for the stability of 
the error rates is increased case selection by clinicians. 
Since fewer autopsies are performed, clinically 
challenging cases may be more likely to be selected for 
autopsy. However, several prospective studies performed 
in the 1960s, 1970s and 1980s have shown that clinicians 
have a poor ability to identify cases that will yield 
‘diagnostic surprises’ [12-14]. A study performed by 
Cameron and colleagues [15] showed that 15% of main 
diagnoses were not conﬁ  rmed by autopsy in cases where 
physicians said they would have requested an autopsy. 
Th   e rate was similar at 14% in cases where physicians said 
they would not have requested an autopsy.
Th  e lack of a decrease in the proportion of missed 
diagnoses during the past decades does not indicate a 
lack of progress in medical science since the types of 
missed diagnoses varied in the diﬀ  erent eras [16]. Rather, 
it suggests that our clinical and technical investigations 
are less sensitive for new disease entities.
Why do autopsies still play an important role in the 
ICU?
Autopsies can be used to check the accuracy of existing 
diagnostic tools
Th   e imperfect correlation between pre- and post-mortem 
ﬁ  ndings illustrates that existing diagnostic tools do not 
always provide 100% certainty about the existence of a 
speciﬁ   c disease entity [5]. Autopsies yield important 
infor  mation on the rates of discrepancies between clini-
cal diagnosis and histology. A few studies investi  gating 
this have been performed in the ICU. Combes and 
colleagues [17] performed the largest, prospective study, 
corroborating the results of other studies performed in 
the ICU; namely, that the overall type I error rate 
averages 10%. A study performed by Roosen and 
colleagues [18] with an autopsy rate of 93% revealed that 
fungal infection, cardiac tamponade, abdominal haemor-
rhage, and myocardial infarction are the diagnoses most 
frequently missed in a medical ICU.
Autopsies allow the accuracy of existing diagnostic 
tools to be checked. One example may clarify this matter. 
Th  e role of Candida spp. in the airways of critically ill 
patients was examined in a prospective, controlled 
autopsy study performed in our medical ICU [19]. A 
Table 1. Classifi  cation of discrepancies between pre- and post-mortem diagnoses (according to Goldman and colleagues [3])
Major: important underlying conditions and all primary causes of death
  Class I: may have altered therapy or survival
  Class II: would not have altered therapy or survival
Minor: unknown preexisting condition not directly related to the cause of death
  Class III: would not have altered therapy or survival
  Class IV: may have altered therapy or survival
Nondiscrepancy
  Class V: complete agreement between clinical and post-mortem diagnosis
Nonclassifi  able
  Class VI: patients died immediately after admission with no diagnostic procedure or refused any diagnostic procedure. Autopsy was unsatisfactory, with no 
  clear fi  ndings and no diagnosis could be established
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24% of French intensivists treat Candida  spp. when 
found in the airways of mechanically ventilated patients. 
However, we did not ﬁ  nd Candida pneumonia at autopsy 
despite the frequent pre-mortem occurrence of Candida 
spp. in the respiratory tract of critically ill patients. Th  is 
ﬁ   nding argues against the use of expensive antifungal 
treatment in mechanically ventilated patients solely on 
the basis of isolation of Candida  spp. from tracheal 
aspirates and broncho-alveolar lavage ﬂ  uid.  Recent 
published guidelines of the Infectious Diseases Society of 
America on the treatment of invasive candidiasis in 
intensive care reinforce this [21].
Autopsies are useful for understanding pathophysiology
Th  ere are several examples of the value of autopsy in 
elucidating pathophysiological mechanisms of disease in 
the ICU. Extensive observational data have shown a 
consistent, almost linear relationship between blood 
glucose levels in hospitalized patients and adverse clinical 
outcomes, even in patients without established diabetes 
[22]. It has never been entirely clear, however, whether 
glycaemia serves as a mediator of adverse outcomes or 
merely as a marker of illness. Several early studies sug-
gested a clinical beneﬁ  t from strict glucose control during 
critical illness [23]. Recently, a large multicentre study 
called into question the beneﬁ  cial  ﬁ   ndings of tight 
glycaemic control [24]. Autopsy might be of help in 
elucidating the potential toxic eﬀ  ects of hyperglycaemia 
on various organs. Vanhorebeek and colleagues [25] used 
post-mortem liver samples from the original Leuven 
study [23] and showed that mitochondrial function in 
hepatocytes was retained in patients with tight glycaemic 
control compared to the patients in the conventional treat-
ment group. Th   ere was, however, no diﬀ  erential eﬀ  ect on 
mitochondrial function of myocytes. Th   is autopsy report 
could encourage clinicians to perform histological and 
molecular studies in order to clarify the mechanisms of 
glucose toxicity and to what extent tight glycaemic 
control should be achieved.
Autopsies are useful in understanding epidemiology and 
describing new disease entities
An illustrative example of the value of autopsy in 
explaining certain epidemiological and pathophysio-
logical features of new disease entities is the description 
of pathology specimens from patients dying of conﬁ  rmed 
2009 inﬂ  uenza A H1N1 infection. Autopsy studies have 
shown that the main pathological changes associated 
with 2009 inﬂ  uenza A H1N1 infection are located in the 
lungs, identifying three distinct histological patterns. 
Ongoing aberrant immune responses in lung specimens 
could be identiﬁ  ed in patients dying of 2009 inﬂ  uenza A 
H1N1 infection [26]. Also, concurrent bacterial infection 
was found in autopsy specimens of 22 of 77 (29%) 
patients, including 10 Streptococcus pneumoniae infec-
tions. Th   ese autopsy ﬁ   ndings underscore both the 
importance of pneumococcal vaccination for persons at 
increased risk for pneumococcal pneumonia and the 
need for early recognition of bacterial pneumonia in 
persons with inﬂ  uenza [27].
Autopsies continue to serve as an invaluable educational tool
Due to the ever-expanding armamentarium of immuno-
suppressant and immunomodulating drugs, there is a 
growing list of potentially lethal and diﬃ   cult to diagnose 
opportunistic infections. Patients with these uncommon 
infections often present in an advanced state of their 
disease, the conditions of which are often discovered only 
post-mortem. Th  e autopsy has an educational role in 
describing the histological features of these advanced 
disease states and their complications.
Moreover, the autopsy can be an integral part of the 
safety analysis of new drugs. Due to detailed brain 
autopsies, natalizumab, a novel antibody directed to the 
adhesion molecule α4 integrin, was identiﬁ  ed as a risk 
factor for development of progressive multifocal leuko-
encephalopathy in patients with Crohn’s disease or 
multiple sclerosis treated with this drug [28].
Shojania and colleagues [11] studied the eﬀ  ect  of 
increasing autopsy rate on the incidence of major 
diagnostic errors. Th   ey found that major errors decreased 
at a rate of 12.4% for every 10% increase in autopsy rate, 
and class I errors decreased at a rate of 17.4% for every 
10% increase in autopsy rate. Th   is points to the important 
educational value of post-mortem examination and we 
believe that the decreasing autopsy rate is contrary to 
progress in medical diagnostics. We think that medical 
students should follow at least some autopsies to 
underline the importance of the necropsy.
However, it needs to be stressed that the procedure 
needs to be done according to certain criteria and ideally 
attended by the intensivist that took care of the patient. 
Th   e autopsy has always been a valid monitor of clinical 
diagnostic performance if it meets four necessary 
conditions, according to Saracci [29]: a high necropsy 
rate (28 to 50%); speciﬁ  ed and stable conditions under 
which necropsies are performed; calculation of sensitivity 
and speciﬁ   city rather than overall accuracy; and an 
estimate of the error in post-mortem diagnoses. Durning 
and Cation [30] showed that autopsy cases were 
frequently evaluated as a valuable educational experience 
by attending physicians.
New, innovative techniques might improve the diagnostic 
yield of autopsies
A very intriguing ﬁ  eld of interest is molecular investi-
gations at autopsy. Even with normal structural ﬁ  ndings, 
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resolve ‘unsolved’ cases of sudden death. Ackerman and 
colleagues [31] report the results of post-mortem 
molecular testing and the identiﬁ  cation of a novel muta-
tion in a young woman who died in the ICU after a near-
drowning secondary to what turned out to be a form of 
congenital long-QT syndrome. Because of this molecular 
ﬁ  nding at autopsy, an asymptomatic sibling carrying the 
same mutation was able to receive prophylactic 
treatment. For sudden cardiac deaths the protocols for 
autopsy recommend freezing a piece of spleen for 
molecular analysis.
Autopsies might protect physicians from subsequent 
malpractice litigation
Among intensivists, the mistaken belief that sophisticated 
diagnostic tests have rendered the autopsy obsolete 
combined with reluctance to ask bereaved families to 
consent to autopsy has substantially reduced interest in 
the procedure. Moreover, there is a misperception that 
autopsies increase physicians’ exposure to malpractice 
claims. Educational eﬀ  orts should overcome these barriers 
(Table 2) [32]. Th   ere must be more attempts to coordinate 
autopsies with the schedules of requesting physicians.
Clinicopathological conferences should take place on a 
regular (for example, monthly) basis. Th   is means a joint 
eﬀ  ort of both intensivists and pathologists. Th  e  clinicians 
need to inform the pathologist about the patient’s 
pre-mortem status, the expected ﬁ   ndings and the 
unsolved questions. Th   e pathologist needs to understand 
the importance of the results of autopsy in medical 
develop  ment. Autopsies can lead to an increased 
awareness for rare and emerging diseases and eventually 
result in better daily clinical practice.
Information for relatives
Th  e information gained by autopsy ﬁ   ndings can help 
relatives to understand the cause of death of their loved 
ones. Sadly enough, autopsy results are often not 
communicated to them. In a study performed by Burton 
and colleagues [9], 78% of relatives reported that autopsy 
results were not discussed.
Overview of recent studies performed in the ICU
Table 3 lists clinical autopsy studies in the ICU setting. 
Th   e amount of major missed diagnoses of class I varied 
between 3 and 16%. Th   ere was no signiﬁ  cant diﬀ  erence in 
the type of hospital (referral or general district hospital) 
or the type of unit (surgical, medical or mixed). Most of 
the studies were retrospective in design, except for the 
study by Combes and colleagues [17]. Th  ey  prospectively 
analyzed autopsies performed on patients who died in a 
tertiary care medical-surgical ICU during 3 years. Monthly 
clinical-pathological meetings were held to compare 
clinical and autopsy diagnoses. During the study, 1,492 
patients were admitted, of whom 315 (21%) died during 
Table 2. Strategies to improve autopsy rate
Eff  orts by the pathological department
  Coordinate autopsies with the schedules of requesting physicians
  Faster processing of the autopsy reports
  Provision of resources for performing autopsies
  Creation of regional autopsy centres 
    Provides opportunities to improve autopsy quality
    Develops strategies for using autopsy results to improve clinical performance
    Improvement of training for pathology residents
    Better education of medical students
  Quality control of performed autopsies (diff  erent pathologists interpreting the same autopsy specimens) in order to improve diagnostic value
  Provide opportunities to improve autopsy quality by specialization
Eff  orts by physicians
  Allow physicians complete discretion in requesting autopsies (arbitrary sampling as a result will augment the numbers of important misdiagnoses)
  Analyse data from regional centres to identify patterns of missed diagnoses and to generate prediction rules that would enhance the process of case 
 selection
  Augment autopsy numbers with widespread use of structured death reviews and structured reports of epidemiological statistics on various diseases 
  encountered in the ICU
  Communicate the conclusion of the autopsy report to the relatives 
Eff  orts by both departments
  Clinicopathological conferences on a monthly basis attended by the treating intensivist, the radiologist and the pathologist
  Interesting cases should be published with the aim of education and improving knowledge of epidemiology
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most frequently erroneously overdiagnosed cancer, endo-
carditis, myocardial infarction and pneumonia. Th  e 
intensivist missed 171 diagnoses.
In all studies, infections were most frequently missed. 
Medical development has led to new treatments, such as 
new cytotoxic agents, and organ and stem cell trans-
plantation, which have led to an increased number of viral 
and fungal infections with unusual clinical presen  tations 
[3,16,33-35]. In a study performed at our medical ICU, 
fungal infections occurred in 16% of deceased patients. In 
30% of all cases, the diagnosis was not considered pre-
mortem [18]. Veress and Alufuzoﬀ   [2] found a signiﬁ  cant 
increase in infectious diseases in autopsy patients, from 
27% in the 1970s to 32% in the 1980s, and an increase in 
undiagnosed infections of 30%. Gerain and colleagues [36] 
studied the causes of death in oncology patients who died 
in an ICU. In 23.5% of all deaths the primary cause was 
infectious disease, with fungal disease in 87.5%. Cancer 
itself was the direct cause of death in only 10%. Silfvast and 
colleagues [37] showed that 62% of class I diagnostic errors 
were found in patients with pneumonia or other already 
known infec  tions. Th  is  ﬁ  nding emphasises the diﬃ   culty of 
diagnosing unexpected or new pathogens in patients with 
existing infections.
Pulmonary embolism remains one of the major missed 
diagnoses throughout the past three decades (8.9%) [38]. 
In autopsied patients who died from pulmonary 
embolism, the diag  nosis was unsuspected in 14 of 20 
(70%). Most of these patients had advanced associated 
disease [38]. As Gold  man postulates, the persistent high 
rate of missed pulmo  nary embolism is more a reﬂ  ection 
of the high mortality of the pathology when this diagnosis 
is missed [35]. Th   e availability of new diagnostic 
techniques can also give misleading information. Th  e 
frequency of a false-positive diagnosis of pulmonary 
embolism (when the clinician ascribed the death to 
pulmonary embolism not conﬁ   rmed at autopsy) rose 
from 33% in 1959 to 44% in 1999/2000 [39].
Intra-abdominal and retroperitoneal bleeding and 
more general acute abdominal complications are under-
diagnosed in the ICU. Altered mental status, narcotic 
medication, immunosuppression and mechanical ventila-
tion make the bedside diagnosis diﬃ   cult. Angiography or 
computed tomography are often not an option in these 
unstable patients and bedside ultrasound is frequently 
inconclusive. Papadakis and colleagues [40] studied the 
diagnostic discrepancy in veteran soldiers receiving 
mechanical ventilation. Th   irty-nine percent of the class I 
errors were potentially treatable abdominal disorders. In 
two-thirds, the errors arose because clinicians failed to 
consider the diagnosis, and not because the clinicians 
had misleading or inconclusive information from 
diagnostic procedures.
Conclusion
Over the past decades, autopsy rates have been declining 
and studies on autopsy ﬁ   ndings are scarce. We are 
Table 3. Overview of recently performed autopsy studies in the ICU setting
         Autopsy  Number  Major  Class  I
   Studied  Type  of  Study  rate  of  error† error
Author Period  population  hospital*  design  (%)  autopsies  (%)  (%)
Roosen et al. [18]  1996  Medical  Referral, Belgium  Retrospective  93  100  36  16
Combes et al. [17]  11/1995 to 10/1998  Mixed  Referral, France  Prospective  53  167  31.7  10.2
Dimopoulos et al. [41]  1999  Mixed  Referral, Belgium  Retrospective  45  222  8.5  5.4
Maris et al. [42]  1/2004 to 12/2005  Mixed  Referral, Belgium  Retrospective  37  289  19  6
Nadrous et al. [33]  1/1998 to 12/2000  Mixed  Referral, USA  Retrospective  33  455  21  4
Tai et al. [16]  1/1994 to 12/1995  Medical  Referral, USA  Retrospective  22  91  19.78  8.79
Mort et al. [43]  7/1986 to 7/1992  Surgical  Referral, USA  Retrospective  29  149  23  9.5
Podbregar et al. [44]  1/1998 to 12/1999  Medical  Referral, Slovenia  Retrospective  46  126  52.4  12
Twigg et al. [45]  6/1996 to 5/1999  Mixed  District, UK  Retrospective  40  97  23.71  4.12
Silfvast et al. [37]  1/1996 to 12/2000  Mixed  Referral, Finland  Retrospective  89  346  5  2.3
Fernandez-Segoviano   5/1983 to 12/1985  Mixed  Referral, Spain  Prospective  51  100  22  7
et al. [46]
Pastores et al. [34]  1/1999 to 9/2005  Oncologic  Referral, USA  Retrospective  13  86  26  17
Ong et al. [47]  1/1997 to 12/1998  Trauma and burns  Referral, USA  Retrospective  97  153  18.95  3
Al-Saidi et al. [48]  11/1994 to 6/1999  Bone marrow  Referral, Canada  Retrospective  47  28  10.7  3.6
   transplant
Gerain et al. [36]  11/1985 to 10/1986  Oncologic  Referral, Belgium  Retrospective  69  34  59  Unknown
*Referral: a hospital that is linked to a university, deals with general admissions and with referrals from other hospitals. †Major error: class I or II according to Goldman’s 
criteria of missed diagnoses [3].
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for many reasons. First, studies have shown that despite 
technical improvements, the frequency of missed 
disorders has not diminished compared to the 1960s and 
1970s. Th   e reason is the advent of several new pathologies 
with more opportunistic infections in an era of HIV and 
inﬂ  uenza A H1N1 pandemics, new immunosuppressive 
treatments for transplant recipients and auto-immune 
diseases. Second, we argue that the post-mortem exami-
na  tion can be useful for relatives, especially if the cause of 
death is not clear. We regret the fact that autopsy results 
are often not reported to the relatives. Moreover, 
clinicians and pathologists do not communicate well with 
each other. Input from the clinician can motivate the 
pathologist to ﬁ  nd new, rare or unsuspected diseases.
Th  e costs of post-mortem examination are negligible 
compared to the overall costs of ICU stay. Since the 
results may improve our daily practice, we should not 
consider the costs as a reason to forestall autopsies.
We ask that the importance of post-mortem examina-
tions be reconsidered, since autopsy remains the ultimate 
tool of accountability for clinical evaluation and manage-
ment of new and old diseases.
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